Search Within

Juliet N Barker

  1. "Elsevier Inc."
Formats
  1. Meeting Abstract (106)
  2. Journal Article (45)
  3. Guidelines (4)
  4. Correspondence (1)
  5. Review (1)
Groups
  1. Bone Marrow Transplant (157)
  2. Center for Hematologic Malignancies (157)
  3. Department of Medicine (157)
  4. Hematologic Malignancies, Division of (157)
  5. CTCR Scholars (103)
  6. Pediatrics, Department of (92)

More Groups

People
  1. Sergio Giralt (101)
  2. Miguel-Angel Perales (86)
  3. Doris Ponce (80)
  4. Andromachi Scaradavou (75)
  5. Esperanza Papadopoulos (68)
  6. Sean Devlin (66)

More People

Years
  1. 2024 (2)
  2. 2023 (1)
  3. 2022 (8)
  4. 2021 (4)
  5. 2020 (13)
  6. 2019 (15)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (142)
  2. Transplantation and Cellular Therapy (15)
Publishers
  1. Elsevier Inc. (157)

Results (157)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comparison of search prognosis algorithms demonstrates the value of HapLogic™-based assessment in predicting the likelihood of identifying 8/8 HLA-allele matched unrelated donors (URD) & receiving an 8/8 URD transplant
    Meeting Abstract

    Davis, E.; Devlin, S. M.; Cooper, C.; Nhaissi, M.; Wells, D. S.; Giralt, S. A.; Papadopoulos, E. B.; Politikos, I.; Barker, J. N.
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • The impact of individual co-morbidities in myeloablative ex vivo CD34+ selected allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Shouval, R.; Fein, J. A.; Devlin, S. M.; Maloy, M. A.; Castillo Flores, N.; Lin, R. J.; Politikos, I.; Sanchez, M.; Scordo, M.; Shah, G. L.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Don't let the HCT-CI fool you: Similar outcomes with myeloablative CD34+ selected allo-HCT compared to unmodified RIC allo-HCT in patients with AML or MDS and high comorbidity scores
    Meeting Abstract

    Pennisi, M.; Cho, C.; Devlin, S. M.; Ruiz, J. D.; Maloy, M. A.; Tomas, A. A.; Castillo, N.; Lin, R. J.; Politikos, I.; Sanchez-Escamilla, M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Burden and impact of geriatric syndromes in 2-year, progression-free survivors of older allogeneic hematopoietic cell transplant recipients - A landmark analysis
    Meeting Abstract

    Lin, R. J.; Baser, R. E.; Elko, T. A.; Korc-Grodzicki, B.; Shahrokni, A.; Maloy, M. A.; Young, J. W.; Tamari, R.; Shah, G. L.; Shaffer, B. C.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • A phase 2 study of F-652, a novel tissue-targeted recombinant human interleukin-22 (IL-22) dimer, for treatment of newly diagnosed acute GVHD of the lower GI tract
    Meeting Abstract

    Ponce, D. M.; Alousi, A. M.; Nakamura, R.; Sandhu, K. S.; Barker, J. N.; Shia, J.; Yan, X; Daley, W. L.; Moore, G.; Fatmi, S.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Outcomes of two chemotherapy-based preparatory regimens compared to tbi-based conditioning when used with CD34(+) selected T-cell depleted alloHCT for high risk hematologic malignancies: Prospective clinical trial NCT 01119066
    Meeting Abstract

    O'Reilly, R. J.; Koehne, G.; Boulad, F.; Heller, G.; Klein, E.; Barker, J. N.; Castro-Malaspina, H.; Curran, K. J.; Hsu, K. C.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Addition of tocilizumab to cyclosporine-a/ mycophenolate mofetil (CSA/MMF) graft-vs-host disease (GVHD) prophylaxis significantly abrogates pre-engraftment syndrome (PES) & severe acute GVHD after adult double unit cord blood transplantation (dCBT)
    Meeting Abstract

    Politikos, I.; Maloy, M. A.; Devlin, S. M.; Naputo, K.; Bhatt, V.; Skinner, K.; Cho, C.; Dahi, P. B.; Giralt, S. A.; Gyurkocza, B.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Ex vivo T cell-depleted hematopoietic stem cell transplantation for adult patients with acute myelogenous leukemia in first and second remission: Long-term disease-free survival with a significantly reduced risk of graft-versus-host disease
    Journal Article

    Montoro, J.; Ceberio, I.; Hilden, P.; Maloy, M. A.; Barker, J.; Castro-Malaspina, H.; Dahi, P.; Koehne, G.; Perales, M. A.; Ponce, D.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Analysis of 154 cord blood unit (CBU) reports demonstrates high variability in potency data and highlights the need for standardization of CBU quality assessment
    Meeting Abstract

    Scaradavou, A.; Wells, D. S.; Nhaissi, M.; Politikos, I.; Davis, E.; Barker, J. N.
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Comparison of double unit cord blood transplants (dCBT) with 8/8 HLA-allele matched related (MRD) or unrelated donor (MUD) T-cell depleted (TCD) transplants in adults with myeloid malignancies: Comparable progression-free survival (PFS)
    Meeting Abstract

    Politikos, I.; Cho, C.; Devlin, S. M.; Maloy, M. A.; Naputo, K.; O'Reilly, R. J.; Scaradavou, A.; Castro-Malaspina, H.; Dahi, P. B.; Gyurkocza, B.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save